Showing results (161-170 of 237) with videos related to
Sort By:
Pageof 24
Ebiomedicine|May 17, 2025
Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024Mhairi J McCormack, Sam Scott, Nicola Logan, et al.BMJ (Clinical Research Ed.)|February 19, 1999
Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study GroupK D Bardhan, S Müller-Lissner, M A Bigard, et al.Viruses|August 26, 2023
Increase in SARS-CoV-2 Seroprevalence in UK Domestic Felids Despite Weak Immunogenicity of Post-Omicron VariantsGrace B Tyson, Sarah Jones, Chloe Montreuil-Spencer, et al.Journal of Virology|January 15, 2005
Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of EnvMargaret J Hosie, Dieter Klein, James M Binley, et al.Journal of Virology|August 8, 1998
DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodiesM J Hosie, J N Flynn, M A Rigby, et al.Pharmacoeconomics|February 8, 2000
Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux diseaseN O Stålhammar, J Carlsson, R Peacock, et al.Viruses|February 24, 2024
Serological and Molecular Investigation of SARS-CoV-2 in Horses and Cattle in Switzerland from 2020 to 2022Julia Hüttl, Katja Reitt, Marina L Meli, et al.Journal of Feline Medicine and Surgery|October 26, 2020
<i>Encephalitozoon cuniculi</i> infection in cats: European guidelines from the ABCD on prevention and managementDiane D Addie, Séverine Tasker, Corine Boucraut-Baralon, et al.Viruses|September 28, 2024
Investigations on the Potential Role of Free-Ranging Wildlife as a Reservoir of SARS-CoV-2 in SwitzerlandJuliette Kuhn, Iris Marti, Marie-Pierre Ryser-Degiorgis, et al.Pageof 24